De la Humildad, la Esperanza: releyendo el Ordo Virtutum de Hildegard von Bingen con Charles Péguy
Revista Historia Autónoma · 30.04.2026 · (28) · 26-48
DOI: 10.15366/rha2026.28.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Historia Autónoma, online erschienen am 30.04.2026. Verfasst von Nadia Smirnova. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
It is the Benedictine abbess, Doctor of the Church, and visionary Hildegard von Bingen to whom we owe the composition of Ordo Virtutum, one of the few surviving medieval liturgical dramas preserved not only textually but also musically. The elements that make up the drama serve a narrative that encapsulates the quintessential human condition: the soul, within which a battle between Good and Evil is waged, placing its free will at the crossroads between perdition and virtue, between pride and humility. Likewise, the late 19th-century French poet Charles Péguy, in his three Mysteries, takes up the same framework to sing of the virtues, granting a particular aureole to hope. The exercise of bringing these two works together combines the poetic and expressive richness and the depth of thought of Hildegard von Bingen and Charles Péguy, offering a broad and multifaceted perspective on the question of human freedom in its correlation with the divine and the earthly.
Zitieren
APA
Smirnova, N. (2026). De la Humildad, la Esperanza: releyendo el Ordo Virtutum de Hildegard von Bingen con Charles Péguy. Revista Historia Autónoma, 26-48. https://doi.org/10.15366/rha2026.28.002
Vancouver
Smirnova N. De la Humildad, la Esperanza: releyendo el Ordo Virtutum de Hildegard von Bingen con Charles Péguy. Revista Historia Autónoma. 2026:26-48. doi:10.15366/rha2026.28.002
BibTeX
@article{Smirnova2026,
author = {Smirnova, Nadia},
title = {De la Humildad, la Esperanza: releyendo el Ordo Virtutum de Hildegard von Bingen con Charles Péguy},
journal = {Revista Historia Autónoma},
year = {2026},
number = {28},
pages = {26--48},
doi = {10.15366/rha2026.28.002}
}
EUVIMED